Bridging Innovators: Wallonia-UK Advanced Therapies Mission 2024

30 Sept – 3 Oct 2024 | United Kingdom

Thibault Helleputte

CEO & co-founder

DNALYTICS

Louvain-La-Neuve, Belgium

2 profile visitsWalloon Participant

Supporting healthcare industry with data sciences since 2005.

About me

I'm a Computing Sciences engineer, also holding a Ph.D. from UCLouvain in Machine Learning and a Master of Management Sciences from the Louvain School of Management.

I am the co-founder and CEO of DNAlytics, a company offering data sciences expertise to the healthcare industry, for R&D, Biomanufacturing and Public Health applications. I'm also invited professor in multiple institutions. Over the years, my work has been awarded among others by IBM, Microsoft or the MIT.

Since 2024 I am also member of the ethics committee on data and AI for the Belgian federal administration.

I'm a husband and father of three, brewer and drummer in my spare time.

My organisation

DNAlytics brings cutting-edge data sciences expertise tailored to the healthcare sector, with a particular focus on driving innovation in advanced therapies and biomanufacturing. Founded in 2012 as a university spin-off by Prof. Pierre Dupont and Dr. Thibault Helleputte, the Belgian SME has rapidly grown into a trusted partner for over 100 collaborations spanning biotech, pharma, medtech, academic institutions, and hospitals.

With extensive experience supporting the development of Advanced Therapy Medicinal Products (ATMPs), DNAlytics understands the unique challenges of the biomanufacturing landscape, from optimizing bioprocesses to ensuring data interoperability. The company has a proven track record of translating complex healthcare data into actionable insights that accelerate product development, streamline production, and enhance regulatory compliance.

DNAlytics’ innovative work is backed by over 50 scientific publications and a portfolio of proprietary and open-source software, downloaded nearly 450,000 times globally. This expertise has been recognized by industry giants like IBM, Microsoft, and MIT, as well as the European Commission, underscoring DNAlytics’ position as a leader in the digital transformation of healthcare and biomanufacturing.

For biomanufacturers developing ATMPs, DNAlytics offers a unique value proposition: a deep understanding of data science, regulatory compliance, and the specific demands of ATMP development, making it an ideal partner for driving forward innovation and efficiency in this rapidly growing field.

Social media

Skills

  • Entrepreneurship
  • innovation
  • Data Sciences
  • Machine Learning
  • biotechnology
  • biomanufacturing

Interests

  • Digital Factory
  • Supporting biomanufacturing

Marketplace (4)